Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Scorpius Holdings Inc (SCPX)

NYSE
Symbol
Exchange
Currency
SCPXNYSEUSD
1HBFrankfurtEUR
Currency in USD
Disclaimer
0.1585
+0.0015(+0.96%)
Closed
Pre Market
0.1640+0.0055(+3.47%)

SCPX Comments

December 12, 2023 8:30am EST - NightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core Assets. Jeff Wolf, Chief Executive Officer of NightHawk and Elusys following the closing, commented, “Given the strength of our CDMO operations at Scorpius, we have made the strategic decision to refocus our efforts around those activities that hold the potential to generate meaningful cash flow while substantially reducing non-core costs and associated overhead. Scorpius booked $3 million in contracted sales in 2022, which has grown to over $20 million in contracted sales thus far in 2023. As contracted sales are generally recognized as revenue as work is performed, we expect to recognize substantial revenue on these booked contracts in 2024. We also have a very significant and growing sales pipeline, which includes contracts from premier pharma and biotech companies, as well as leading research institutes. We expect to close a number of new contracts before year-end and believe the growth in our sales pipeline is strong validation of the meaningful investments we have made in our Scorpius subsidiary. As we continue to grow our revenue and leverage our fixed costs, we expect our CDMO business to generate high margins and long-term profitability.”
With Hamas attacks in Israel, perhaps ANTHIM can be sold more as countermeasure in case of attacks with Anthrax Exposure?
I am reading some comments: Target price $26.25 High $35.00 Low $20.00 is 138.20% Upside. it is now at 0,60$!!!
0,44 dollars now
0,32 today
What happened?
Now is actually the time to buy. GL Looking for 17$ but short term 5-7$ pop first.
it's at 0.44 dollars. someone knows why?
Now is actually the time to buy. GL Looking for 17$ but short term 5-7$ pop first.
time to buy
https://seekingalpha.com/news/3709052-heat-biologics-expands-rd-and-pre-clinical-capabilities
https://seekingalpha.com/news/3705412-heat-biologics-records-biggest-one-day-gain-in-over-four-months?utm_source=investing.com&utm_medium=referral
Heat Biologics (HTBX) ticks higher on U.S. Patent Application Titled 'GP96-BASED CANCER THERAPY'
Will be at 9$ on the next 3 months. Who want to bet?
its about nothing. In 3 months they need at least 20
0,32 after 2 years and half
Wolf, what are you Shareholders are struggling
Endless Fall A company without vision
In... someone else?
once the non vacines (moderna astra phizer) are found to be unsafe htbx will sky rocket. especially with its higher viability and the cancer connection.
earnings?
why rising up ?
 if you have 15000 4 in a single stock like this you must have a wallet about 2 million dollar....o if you have all money in this stock you  are a noob  ahahahhahaah
 don't understand, I bought 5000 stocks on 3,43 and paid 15K Actually value is now 5000 x 10, so 50K. And i have even stocks on TRXC, BNGO, JAGX....
  u had to sold them in last  June for 12$, then buy again after split for 5$ and sell again weak ago for 18$ - profit would be 110k
Premarket up 30% ?
37%
The trend Is down...I think we will aspect a lot of month before ti arrive at 2€, price ti offering,..No news from socety...
over 30$ in Summer
picked-up another batch at 9.48
Stock Trch buy special dividend
TipRanks just report HTBX is strong buy . Target price $26.25 High $35.00 Low $20.00 is 138.20% Upside.
hold
And people said this is a garbage company.
Its current market cap is less than 300M$. Taking into account its more than likely future income,its fair price should be at least 40$
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.